Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene Phase 3 in Japanese Alcohol Dependence
NCT02364947Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Feb 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalmefene in alcohol dependence, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Feb 2015; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT02364947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364947.